Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 9
2004 1
2005 6
2006 3
2007 3
2008 3
2009 7
2010 6
2011 3
2012 5
2013 9
2014 7
2015 7
2016 9
2017 2
2018 7
2019 8
2020 3
2021 6
2022 10
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
BRCAness in prostate cancer.
Bednarz-Knoll N, Eltze E, Semjonow A, Brandt B. Bednarz-Knoll N, et al. Among authors: semjonow a. Oncotarget. 2019 Mar 29;10(25):2421-2422. doi: 10.18632/oncotarget.26818. eCollection 2019 Mar 29. Oncotarget. 2019. PMID: 31069005 Free PMC article. No abstract available.
Active surveillance for low-risk prostate cancer.
Bangma CH, Bul M, van der Kwast TH, Pickles T, Korfage IJ, Hoeks CM, Steyerberg EW, Jenster G, Kattan MW, Bellardita L, Carroll PR, Denis LJ, Parker C, Roobol MJ, Emberton M, Klotz LH, Rannikko A, Kakehi Y, Lane JA, Schröder FH, Semjonow A, Trock BJ, Valdagni R. Bangma CH, et al. Among authors: semjonow a. Crit Rev Oncol Hematol. 2013 Mar;85(3):295-302. doi: 10.1016/j.critrevonc.2012.07.005. Epub 2012 Aug 9. Crit Rev Oncol Hematol. 2013. PMID: 22878262 Review.
Tumor markers in prostate cancer I: blood-based markers.
Shariat SF, Semjonow A, Lilja H, Savage C, Vickers AJ, Bjartell A. Shariat SF, et al. Among authors: semjonow a. Acta Oncol. 2011 Jun;50 Suppl 1(Suppl 1):61-75. doi: 10.3109/0284186X.2010.542174. Acta Oncol. 2011. PMID: 21604943 Free PMC article. Review.
Efficient Augmented Intelligence Framework for Bladder Lesion Detection.
Eminaga O, Lee TJ, Laurie M, Ge TJ, La V, Long J, Semjonow A, Bogemann M, Lau H, Shkolyar E, Xing L, Liao JC. Eminaga O, et al. Among authors: semjonow a. JCO Clin Cancer Inform. 2023 Sep;7:e2300031. doi: 10.1200/CCI.23.00031. JCO Clin Cancer Inform. 2023. PMID: 37774313 Free article.
Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men: the PROBASE trial.
Arsov C, Becker N, Hadaschik BA, Hohenfellner M, Herkommer K, Gschwend JE, Imkamp F, Kuczyk MA, Antoch G, Kristiansen G, Siener R, Semjonow A, Hamdy FC, Lilja H, Vickers AJ, Schröder FH, Albers P. Arsov C, et al. Among authors: semjonow a. Eur Urol. 2013 Dec;64(6):873-5. doi: 10.1016/j.eururo.2013.05.022. Epub 2013 May 14. Eur Urol. 2013. PMID: 23707067 Clinical Trial. No abstract available.
Expression Patterns and Corepressor Function of Retinoic Acid-induced 2 in Prostate Cancer.
Besler K, Węglarz A, Keller L, von Amsberg G, Bednarz-Knoll N, Offermann A, Stoupiec S, Eltze E, Semjonow A, Boettcher L, Schneegans S, Perner S, Hauch S, Todenhöfer T, Peine S, Pantel K, Wikman H, Werner S. Besler K, et al. Among authors: semjonow a. Clin Chem. 2022 Jul 3;68(7):973-983. doi: 10.1093/clinchem/hvac073. Clin Chem. 2022. PMID: 35652463
104 results